Vorinostat and Concomitant Whole Brain Radiation Therapy in Patients With Brain Metastases: A Randomized, Double-blind, Placebo-controlled, Phase II Study

Trial Profile

Vorinostat and Concomitant Whole Brain Radiation Therapy in Patients With Brain Metastases: A Randomized, Double-blind, Placebo-controlled, Phase II Study

Discontinued
Phase of Trial: Phase II

Latest Information Update: 07 Jan 2014

At a glance

  • Drugs Vorinostat (Primary)
  • Indications Brain metastases; Breast cancer; Lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jan 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 25 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top